Stockscreener 앱 받기
251.91
0.59%
-1.49
시간 외 거래:
251.91
Axsome Therapeutics Inc 주식(AXSM)의 최신 뉴스
3 Under-the-Radar Stocks to Buy and Hold for a Decade - The Motley Fool
Axsome presents data on narcolepsy treatments at sleep conference By Investing.com - Investing.com South Africa
Axsome presents data on narcolepsy treatments at sleep conference - Investing.com
Axsome Therapeutics Presents New Data on AXS-12 and Solriamfetol at SLEEP 2026 Conference - Quiver Quantitative
Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026 - GlobeNewswire
Axsome Therapeutics (AXSM) Stock Analysis: 57% Revenue Growth Propels Exciting Prospects - DirectorsTalk Interviews
Landscape Capital Management L.L.C. Sells 3,983 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
First Turn Management LLC Has $37.79 Million Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Nicholas Investment Partners LP Purchases 42,907 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Eventide Asset Management LLC Sells 175,172 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
The Technical Signals Behind (AXSM) That Institutions Follow - Stock Traders Daily
Rhenman & Partners Asset Management AB Reduces Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics’ Q4 Numbers Beat Wall Street Expectations: Analyst Sees Over 23% Upside For Stock - Stocktwits
Axsome therapeutics director Roger Jeffs sells $141,655 in shares By Investing.com - Investing.com India
Axsome therapeutics director Roger Jeffs sells $141,655 in shares - Investing.com UK
Axsome Therapeutics, Inc. (AXSM) Latest Stock News & Headlines - Yahoo Finance
Agitation in Alzheimer's Disease Market to Register Immense Growth at a CAGR of 14.9% During the Forecast Period (2026-2036) | DelveInsight - PR Newswire
Axsome Therapeutics, Inc. $AXSM Shares Sold by Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. - MarketBeat
Jefferies raises Axsome stock price target to $380 on sales outlook By Investing.com - Investing.com South Africa
Jefferies raises Axsome stock price target to $380 on sales outlook - Investing.com Canada
Axsome Therapeutics (NASDAQ:AXSM) Reaches New 12-Month HighShould You Buy? - MarketBeat
Clearbridge Investments LLC Sells 11,341 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics (AXSM) 10K Form and Latest SEC Filings 2026 - MarketBeat
Axsome Therapeutics readies Auvelity Alzheimer's agitation launch, expands CNS pipeline - MSN
Insider Selling: Axsome Therapeutics (NASDAQ:AXSM) Director Sells 643 Shares of Stock - MarketBeat
Axsome Therapeutics director Susan Mahony sells $145,017 in shares By Investing.com - Investing.com India
Axsome Therapeutics director Susan Mahony sells $145,017 in shares - Investing.com UK
Axsome therapeutics director Mark Coleman sells $160,107 in stock By Investing.com - Investing.com India
Axsome therapeutics director Mark Coleman sells $160,107 in stock - Investing.com
Axsome adopts new executive severance and control plan - The Globe and Mail
Axsome Therapeutics(AXSM.US) 10% Shareholder Sells US$11.97 Million in Common Stock - Moomoo
Axsome Therapeutics stock hits all-time high at 242.5 USD By Investing.com - Investing.com Canada
Axiom Investors LLC DE Purchases 14,137 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics CEO Herriot Tabuteau sells $11.97m in stock - Investing.com India
Axsome Therapeutics CEO Herriot Tabuteau sells $11.97m in stock By Investing.com - Investing.com Australia
[144] Axsome Therapeutics, Inc. SEC Filing - Stock Titan
Axsome Therapeutics (AXSM) sets new executive severance and change in control terms - Stock Titan
Axsome Therapeutics (AXSM) investors approve directors, auditor and executive pay - Stock Titan
Axsome Therapeutics (NASDAQ: AXSM) grants director 1,721 restricted stock units - Stock Titan
Axsome Therapeutics (AXSM) director awarded 1,721 restricted stock units - Stock Titan
Axsome (NASDAQ: AXSM) CEO sells 49,670 shares after expiring option exercise - Stock Titan
Axsome (AXSM) CFO sells 33K shares after exercising long-held options - Stock Titan
Axsome Therapeutics (AXSM) director awarded 1,721 RSUs vesting in one year - Stock Titan
Axsome (AXSM) director receives 1,721 restricted stock units as compensation - Stock Titan
Axsome Therapeutics, Inc.Common Stock (NQ: AXSM - FinancialContent
Axsome Therapeutics stock hits all-time high at 242.5 USD - Investing.com
AXSM: AUVELITY's new approval and sales force expansion drive strong growth in CNS markets - TradingView
Axsome Therapeutics, Inc. (AXSM) Stock Analysis: A Biotech Dynamo with a 16% Upside Potential - DirectorsTalk Interviews
Axsome marks ending of all patent disputes related to Sunosi - MSN
Norges Bank Makes New $90.49 Million Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics Readies Auvelity Alzheimer’s Agitation Launch, Expands CNS Pipeline - inkl
1.27%
1.43%
자본화:
|
볼륨(24시간):